Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Karlsson

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
BMC Cancer|June 3, 2014
Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaToshima Z Parris, Luaay Aziz, Anikó Kovács, et al.
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
Biological Psychiatry|February 9, 2010
Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memoryHåkan Fischer, Lars Nyberg, Sari Karlsson, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Breast Cancer Research and Treatment|March 4, 2021
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trialCarina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, et al.
Molecular Therapy. Oncology|April 30, 2026
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesisElla Ittner, Lucas Werner, Hugo Swenson, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Breast Cancer Research : BCR|April 6, 2023
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancerSlavica Janeva, Ellen Krabbe, Toshima Z Parris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2017
A Novel 18-Marker Panel Predicting Clinical Outcome in Breast CancerJana Biermann, Szilárd Nemes, Toshima Z Parris, et al.
Familial Cancer|June 14, 2005
A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniquesAnnika Bergman, Anna Flodin, Yvonne Engwall, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
BMC Cancer|June 3, 2014
Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinomaToshima Z Parris, Luaay Aziz, Anikó Kovács, et al.
Scientific Reports|May 16, 2020
Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypesHanna Engqvist, Toshima Z Parris, Jana Biermann, et al.
Biological Psychiatry|February 9, 2010
Simulating neurocognitive aging: effects of a dopaminergic antagonist on brain activity during working memoryHåkan Fischer, Lars Nyberg, Sari Karlsson, et al.
BMC Cancer|September 19, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer typesPeter Larsson, Daniella Pettersson, Hanna Engqvist, et al.
Breast Cancer Research and Treatment|March 4, 2021
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer: results from the randomized SweBCG91RT trialCarina Strell, Axel Stenmark Tullberg, Reidunn Jetne Edelmann, et al.
Molecular Therapy. Oncology|April 30, 2026
LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesisElla Ittner, Lucas Werner, Hugo Swenson, et al.
Scientific Reports|August 10, 2024
Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancersPeter Larsson, Maxim Olsson, Sithumini Sarathchandra, et al.
Breast Cancer Research : BCR|April 6, 2023
Clinical evaluation of molecular surrogate subtypes in patients with ipsilateral multifocal primary breast cancerSlavica Janeva, Ellen Krabbe, Toshima Z Parris, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 8, 2017
A Novel 18-Marker Panel Predicting Clinical Outcome in Breast CancerJana Biermann, Szilárd Nemes, Toshima Z Parris, et al.
Familial Cancer|June 14, 2005
A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniquesAnnika Bergman, Anna Flodin, Yvonne Engwall, et al.
Pageof 18